Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
This article clarifies which crypto transactions trigger wash sale rules in 2026 and how they alter reported gains and tax liability.
25,192 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
In 2026, Interactive Brokers rolled out a major update with lower costs, broader market access, and AI-driven researc...
Retirees want to secure their legacy. This guide explains how generation-skipping trusts in 2026 can help you pass we...
Oil traded at $106.52 per barrel for Brent on May 6, 2026, at 8:30 a.m. ET, marking a sharp drop from yesterday and s...
Investors are watching Health Catalyst as healthcare data analytics gain budget priority. This guide breaks down what...
Beam Global is shaping the clean-energy charging space. In this piece, we break down what Q1 2026 earnings might reve...
As KB unveils its Q1 2026 results, investors will parse revenue signals, margin dynamics, and guidance. This guide br...
Tuniu faces a shifting travel landscape as 2026 unfolds. This guide breaks down what to watch in tuniu (tour) 2026 ea...
A market wobble in 2026 didn’t push Berkshire into a rush of deals. Learn what Warren Buffett's stance on cash, risk,...
Two very different apparel plays: FIGS targets a niche medical market with growth potential, while Gildan Activewear ...
A Compass-affiliated luxury brokerage led by Ivan Chorney and Michael Martirena secured a top-20 spot in RealTrends V...
AT&T and Verizon report Q1 2026 results as fiber deals reshape their paths. This analysis weighs dividends, cash flow...